Cummings JL (2003), Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry 11(2):131-145.
Cummings JL, Back C (1998), The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am J Geriatr Psychiatry 6(2 suppl 1):S64-S78.
Cummings JL, Mega M, Gray K et al. (1994), The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44(12):2308-2314.
Dartigues JF, Goulley F, Bourdeix I et al. (2002), [Rivastigmine in current clinical practice in patients with mild to moderate Alzheimer's disease.] Rev Neurol (Paris) 158(8-9):807-812.
Erkinjuntti T (2002), Treatment options: the latest evidence with galantamine(Drug information on galantamine) (Reminyl). J Neurol Sci 203-204:125-130.
Feldman H, Gauthier S, Hecker J et al. (2001), A 24-week, randomized, double-blind study of donepezil(Drug information on donepezil) in moderate to severe Alzheimer's disease. [Published erratum Neurology 57(11):2153.] Neurology 57(4):613-620 [see comment].
Galynker I, Ieronimo C, Miner C et al. (1997), Methylphenidate(Drug information on methylphenidate) treatment of negative symptoms in patients with dementia. J Neuropsychiatry Clin Neurosci 9(2):231-239.
Gauthier S, Feldman H, Hecker J et al. (2002), Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr 14(4):389-404.
